Stella Pharma Corporation (TYO:4888)
Japan
· Delayed Price · Currency is JPY 383.00
+26.00 (7.28%)
May 30, 2025, 3:30 PM JST
Stella Pharma Revenue
In the fiscal year ending March 31, 2025, Stella Pharma had annual revenue of 961.00M JPY with 257.25% growth. Stella Pharma had revenue of 707.00M in the quarter ending March 31, 2025, with 924.64% growth.
Revenue
961.00M
Revenue Growth
+257.25%
P/S Ratio
13.56
Revenue / Employee
21.84M
Employees
44
Market Cap
13.04B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |